Alzheimer's & Dementia Outreach, Recruitment & Engagement Resources
Manage Research Operations
Displaying 1 - 10 of 42 resources.
- This article provides the success rates for different recruitment methods used in a large-scale Alzheimer’s disease risk reduction trial.
- This resource describes the recruitment plan for an upcoming clinical trial that tests the ability of the eRADAR tool to identify patients that may have undiagnosed dementia.
- This resource provides recommendations for how to engage people living with dementia in all stages of clinical research.
- Rutgers has created a toolkit for community research based on input from community-based organizations.
- Duke Aging Center has a website on the 5Ts framework — a tool to help researchers employ best practices in the inclusion of older adults in their research studies.
- This review article presents a framework for advance care planning clinical trials that are embedded into existing health care.
- This resource describes a support program in which dementia caregivers are matched Dementia Ambassadors trained to educate caregivers and provide appropriate referrals.
- This resource explores how academic health centers can more closely engage with their surrounding communities.
- Researchers looked at how enrollment factors made a difference, broken out by race, on the progression of mild cognitive impairment and dementia. Using Alzheimer’s Disease Research Center data, they examined the rate of impairment between white participants and Black participants with age-at-progression survival models.
- According to the article authors, the ideal participants for Alzheimer's disease clinical trials would show cognitive decline in the absence of treatment (i.e., placebo arm) and also would be responsive to the therapeutic intervention being studied (i.e., drug arm). This investigation tested whether machine learning models can effectively predict cognitive decline in people with mild to moderate Alzheimer’s disease during the timeframe of a phase III clinical trial. Data from 202 participants...